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Central elements in the infection of mammalian cells with viral, bacterial and parasitic pathogens include the adhesion of the pathogen to
surface receptors of the cell, recruitment of additional receptor proteins to the infection-site, a re-organization of the membrane and, in particular,
the intracellular signalosome. Internalization of the pathogen results in the formation of a phagosome that is supposed to fuse with lysosomes to
form phagolysosomes, which serve the degradation of the pathogen, an event actively prevented by some pathogens. In summary, these changes in
the infected cell permit pathogens to trigger apoptosis (for instance of macrophages paralysing the initial immune response), to invade the cell and/
or to survive in the cell, but they also serve the mammalian cell to defeat the infection, for instance by activation of transcription factors and the
release of cytokines. Distinct membrane domains in the plasma membrane and intracellular vesicles that are mainly composed of sphingolipids
and cholesterol or enriched with the sphingolipid ceramide, are critically involved in all of these events occurring during the infection. These
membrane structures are therefore very attractive targets for novel drugs to interfere with bacterial, viral and parasitic infections.
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Host–pathogen interactions are central for the infection of
mammalian cells with pathogens, but also for the defence of the
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involve the signaling apparatus of the infected cell and result,
for instance, in activation of tyrosine and serine/threonine
kinases, small G-proteins, phospholipases, sphingomyelinases
or transcription factors to name a few.
The plasma membrane is a central element in the interaction
of the pathogen with the host and studies in the recent years
revealed that distinct domains in the membrane of mammalian
cells are of particular importance for the infection with many
pathogens. Biological membranes primarily consist of sphin-
golipids, cholesterol and other (glycero)phospholipids. The
initial model of the cell membrane by Singer and Nicholson [1]
suggested weak interactions between lipid molecules in the cell
membrane resulting in a statistical distribution of lipid
molecules and a free flotation of proteins in the cell membrane.
However, today it is believed that lipids in the cell membrane
are organized and cluster in very small domains also named
rafts. For instance, sphingolipids and cholesterol preferentially
interact with each other resulting in a spontaneous separation of
these lipids from other phospholipids in the cell membrane. At
least two types of lipid organization in the membrane can be
envisioned: A lateral phase separation by interactions of the
lipids in the main layer of the cell membrane results in the
formation of distinct domains. A vertical phase separation
results in a different composition of the bilayers in biological
membranes. Lipid rafts are very small membrane domains (less
than 50nm diameter) that are mainly composed of (glyco-)
sphingolipids and cholesterol [2–4]. Sphingolipids contain a
sphingosine base backbone, the linkage of an acyl-chain with
typically chain lengths of C16 through C26 chain to this
backbone via an amide bond results in the formation of
ceramide. Binding of a phosporylcholine head group results in
the formation of sphingomyelin, binding of carbohydrates in
cerebrosides, etc. Cholesterol is composed of a sterol-ring
system, which is highly hydrophobic, and the 3-hydroxy-
moiety, the only hydrophilic part of the molecule. Cholesterol is
much smaller than sphingolipids and does not contain a long
tail. The small cholesterol sterol-ring system and the ceramide
moiety of sphingomyelin interact via hydrogen bonds and
hydrophobic van der Waal interactions. Further hydrophilic
interactions between sphingolipid headgroups promote the
lateral association of sphingolipids and cholesterol. These
interactions result in the separation of sphingolipids and
cholesterol from other phospholipids in the cell membrane
and the formation of distinct microdomains. Cholesterol is
supposed to stabilize these microdomains by filling the voids
between the large and bulky glycosphingolipids [2]. Therefore,
drugs as cyclodextrin, nystatin and filipin that interfere with the
cholesterol metabolism destroy these membrane microdomains.
These microdomains were termed rafts. Rafts seem to be
exclusively present in the outer leaflet of the cell membrane. At
present, it is unknown whether similar structures exist in the
inner leaflet of the cell membrane.
Caveolae are defined as small invaginations within the cell
membrane [5–7], which can be detected by electron micros-
copy. Caveolae may contain membrane rafts and they are also
composed of sphingolipids and cholesterol, but contain perdefinition the protein caveolin [5]. Caveolin 1 is a 22kDa
palmitoylated, cholesterol-binding protein, which is required
for the formation of caveolae. The protein contains a stretch of
33 amino acids that mediates its association with the cell
membrane.
Studies in the last years identified a novel membrane domain
that is involved in signaling via receptors, the mediation of
cellular stress and infection of mammalian cells with some
pathogens. These studies demonstrated that activation via CD95
[8,9] and CD40 [10], but also CD20 [11], the Interleukin-1
receptor [12], the PAF-receptor [13,14], CD5 [15], LFA-1 [16],
FcγRII [17], DR5 [18], CD28 [19], TNF [20,21], with stress-
stimuli as some chemotherapeutic drugs [22–25], UV-light
[26–28], irradiation [29,30], oxygen radicals [31] and infection
with Neisseriae gonorrhoeae [32], Pseudomonas aeruginosa
[33], Staphylococcus aureus [34], rhinovirus [35] or Sindbis
virus [36] results in activation of the enzyme acid sphingomye-
linase. The acid sphingomyelinase hydrolizes sphingomyelin to
release ceramide in the outer leaflet of the cell membrane [8,37].
Ceramide molecules have the tendency to interact with each
other to form ceramide-enriched microdomains [38,39]. In
addition, ceramide functions as a fusogen triggering the
spontaneous fusion of ceramide-enriched membrane micro-
domains into large ceramide-enriched membrane macrodo-
mains [38,39]. These domains were visualized on fixed and
non-fixed cells employing different antibodies to ceramide and,
thus, are therefore accessible to direct studies [40]. Furthermore,
Kinnunen et al. treated liposomes composed of sphingomyelin,
cholesterol and sphingolipids with an immobilized sphingo-
myelinase [41]. This treatment resulted in the formation of
ceramide-enriched membrane domains in vitro [41], a finding
that was also confirmed by several atomic force microscopy and
biophysical studies [42–44].
In general, rafts, caveolae and ceramide-enriched membrane
domains are characterized by a reduced lateral mobility, a
change of the membrane thickness and, in particular, a
composition different from other parts of the membrane. The
latter feature seems to be in particular important to permit these
domains to function as a sorting domain for proteins. Many
studies in the last years indicated that a change in the
composition of rafts and membrane domains results in the re-
organization of membrane proteins. For instance, stimulation of
T-cells via the antigenic T-cell receptor/CD3-complex resulted
in a dramatic change of the protein composition in rafts
suggesting that rafts are critically involved in the re-organiza-
tion of the signalosom upon cellular stimulation [45].
At present the mechanisms that mediate the preferential
partitioning of proteins into rafts or the exclusion from rafts,
respectively, are unknown. Studies from our laboratory
employed the CD40-receptor to show that at least for this
receptor the transmembranous domain determines the prefe-
rential partitioning of this receptor into ceramide-enriched
membrane domains after stimulation [46]. The transmembra-
nous domain of CD40, a molecule that translocates into
ceramide-enriched membrane platforms upon stimulation with
CD40-ligand or stimulatory anti-CD40 receptor antibodies, was
replaced with the transmembranous domain of CD45, which
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chimeric protein composed of the extra- and intracellular domain
of CD40 and the transmembranous domain of CD45. These
studies showed that the transmembranous domain determined
the translocation of CD40 into ceramide-enriched membrane
platforms upon stimulation. Partitioning of the transmembra-
nous domain in ceramide-enriched membrane platforms might
be mediated by preferred hydrophobic interactions between the
transmembranous domain of CD40 with ceramide-enriched
membrane domains, but also the length and conformation of the
transmembranous domain.
Studies within the last year revealed that a wide range of
pathogens including bacteria, viruses, parasites and even prions
employ rafts, caveolae or raft-derived membrane domains to
infect mammalian cells. These pathogens include bacteriae as
Neissseriae gonorrhoeae [32,47], Pseudomonas aeruginosa
[33], Escherichia coli [48], Staphylococcus aureus [34,49],
Mycobacteria tuberculosis [50], Chlamydia trachomatis [51],
Salmonella species [52], Shigella flexneri [53], viruses as HIV
[54], Influenza virus [55], Epstein–Barr virus [56], Echovirus
[57], Rhinovirus [35], parasites as Plasmodium falciparum [58]
and Toxoplasma gondii [59] and also prions [60] to name a few.
Rafts, caveolae and ceramide-enriched membrane domains are
involved in many aspects of the infection, for instance
internalization of the pathogen, intracellular maturation of
phagosomes, lysis and fusion, respectively, of phagosomes,
activation of intracellular signaling molecules, induction of cell
death upon infection and release of cytokines. These processes
will be discussed in the following chapters for several
pathogens, which may serve as examples to describe paradigms
of the role of distinct membrane domains in host–pathogen
interactions.
2. Neisseria gonorrhoeae
Neisseriae gonorrhoeae, bacteriae that cause Gonorrhoea,
were one of the first bacteria identified to employ membrane
lipids and membrane domains to infect human epithelial cells.
Initial studies in 1997 by Grassmé et al. demonstrated that
N. gonorrhoeae activate the acid sphingomyelinase within
minutes after initiation of the infection of human epithelial cells
resulting in hydrolysis of sphingomyelin and release of ceramide
[32]. Further findings recapitulated an activation of the acid
sphingomyelinase and a release of ceramide in macrophages
upon infection with N. gonorrhoeae [47]. The acid sphingo-
myelinase is a lysosomal protein, which, however, can be also
secreted or translocated onto the extracellular leaflet of the cell
membrane upon cellular infection with pathogens [8,61]. Cells
either deficient for the acid sphingomyelinase or treated with
imipramine, which triggers a proteolytic degradation of the acid
sphingomyelinase [62], resisted the infection with and failed to
internalize N. gonorrhoeae. Subsequent studies by Hauck et al.
demonstrated that infection of human cells with N. gonorrhoeae
occurs at clustered rafts that form membrane macrodomains
upon infection [63]. These membrane platforms served to recruit
and cluster receptors of N. gonorrhoeae, i.e. CEACAM 3, and
the small G-protein Rac that is critically involved in uptake of thebacteria. Thus, ceramide-enriched membrane domains seem to
re-organize receptors and the intracellular signalosoms mediat-
ing internalization of N. gonorrhoeae.
3. Escherichia coli
E. coli-infections belong to the most common infections
manifesting as gastro-intestinal and urinary tract infections.
E. coli binds to epithelial cell surfaces via the FimH adhesin,
a mannose-binding domain on bacterial fimbri [48]. Fim H
binds to CD48 and triggers the uptake of E. coli into
phagosomes. However, Fim H-positive bacteria are capable to
prevent the fusion of the phagosome with lysosomes and are,
thus, able to survive and even replicate in intracellular vesicles.
Fim H-initiated internalization of E. coli is mediated via
clustered lipid rafts or membrane platforms [48]. In contrast,
opsonized E. coli are internalized by a clathrin-mediated
pathway. It is interesting to note that pathogens as N. gono-
rrhoeae and E. coli obviously developed similar uptake
mechanisms to avoid intracellular digestion.
Since E. coli binds to CD48, a GPI-linked protein, which is
presumably constitutively present in rafts, it might be possible
that clustering of rafts is a consequence of CD48-clustering
upon binding of E. coli Fim H to several CD48-molecules. In
this model lipids would interact with a protein, i.e. CD48, and
clustering of the protein would result in clustering of lipid
shells.
Alternatively or in addition, respectively, CD48 binding
might result in a change of cellular lipid metabolism and an
alteration of the lipid composition of rafts that promotes the
fusion of rafts to a membrane platform.
The central function of rafts for internalization of E. coli was
illustrated by the use of drugs that extract cholesterol from and
destroy rafts. Pre-treatment with these drugs, i.e. filipin, nystatin
and cyclodextrin, significantly inhibited Fim H-mediated
uptake of E. coli [48]. Although these drugs are not specific
and may have additional effects, these studies strongly suggest a
central role of sphingolipid- and cholesterol-enriched mem-
brane rafts for the uptake of E. coli.
Similar findings were observed for the interaction of E. coli
with uro-epithelial cells, which is mediated by binding of Fim H
to uroplakin-1a, a protein on the luminal surface of bladder cells
[64]. Uroplakin-1a localizes to rafts and seems to mediate
internalization of E. coli in uro-epithelial cells by a modification
and clustering of rafts. Disruption of rafts by the above-
described cholesterol-extracting reagents prevented E. coli-
uptake into uro-epithelial cells supporting the notion that these
structures are central for the invasion of epithelial cells with
E. coli.
In summary, these studies indicate that rafts are central for
the uptake of E. coli via clustering of rafts and the formation of
membrane platforms.
4. Pseudomonas aeruginosa
Infections with P. aeruginosa belong to the most severe
infections in patients with cystic fibrosis, sepsis or in immuno-
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infections is indicated by the fact that approximately 20% of
patients suffering from P. aeruginosa bacteremia die [65,66]. The
mortality increases to 30%–50%, if a P. aeruginosa bacteremia is
associated with further health problems such as surgery or
pneumonia. Moreover, 40% of deaths in patients with ventilator-
associated pneumonia are directly caused by P. aeruginosa
[65,66]. However, most important are P. aeruginosa infections in
children with cystic fibrosis. Once past early childhood almost all
of these patients suffer from recurrent and finally chronic
P. aeruginosa pneumonia, one of the primary causes of lung
destruction in these patients.
Infection of mammalian epithelial cells with P. aeruginosa
results in uptake of the bacteria, induction of apoptosis in
infected cells and release of several pro-inflammatory
cytokines including Interleukin (IL)-1, IL-6, IL-8 and IL-18
[67–69].
Studies published by our group demonstrated that
infection of mammalian epithelial cells with pathogenic P.
aeruginosa strains triggers a clustering of small membrane
rafts to large membrane platforms [33] (Fig. 1). Destruction
of rafts by extraction of cholesterol with β-cyclodextrin,
nystatin and filipin, prevented the infection of mammalian
epithelial cells with P. aeruginosa and inhibited the uptake ofFig. 1. Pseudomonas aeruginosa triggers the formation of membrane platforms to inf
results in aggregation of rafts and the formation of cholera toxin-positive membrane p
with P. aeruginosa. (printed with permission from Nature Medicine).P. aeruginosa into and induction of apoptosis in host cells
[33,70]. On the other hand destruction of rafts resulted in an
uncontrolled release of cytokines from the cells suggesting
that rafts are also involved in control of bacterial infections,
at least for P. aeruginosa. This notion was confirmed by in
vivo studies that demonstrated the inability of mice that were
treated by intratracheal injection with cyclodextrin, nystatin
or filipin, to control a pulmonary infection with P. aeruginosa
[33].
Recent studies by G. Pier et al. also demonstrated that rafts
are critically involved in internalization of P. aeruginosa, NFκB
nuclear translocation and apoptosis upon infection with
P. aeruginosa, events that were prevented by treatment of
the cells with β-cyclodextrin [71].
Further studies demonstrated that P. aeruginosa infection
of epithelial cells results in a rapid activation of the acid
sphingomyelinase [33]. Activated acid sphingomyelinase
translocated onto the extracellular leaflet, released ceramide
and mediated the formation of large ceramide-enriched
membrane platforms (Fig. 2). Genetic deficiency of the acid
sphingomyelinase prevented the formation of ceramide-
enriched membrane platforms, the induction of apoptosis of
infected cells, internalization of P. aeruginosa and resulted in
an uncontrolled release of cytokines. This pattern paralleledect mammalian cells. Infection of human nasal epithelial cells with P. aeruginosa
latforms. Overlays (right panels) demonstrate the co-localization of cholera toxin
Fig. 2. Schematic scheme of the role of rafts and membrane platforms for the
infection of mammalian cells by bacterial, viral and parasitic pathogens. Rafts
may either be converted into membrane platforms or directly serve many aspects
of the infection including internalization of the pathogens, induction of
apoptosis, the release of cytokines, the formation of reactive oxygen species, etc.
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above. Acid sphingomyelinase-deficient mice were unable to
eliminate P. aeruginosa after pulmonary infection and suc-
cumbed to a septic shock indicating the in vivo significance of
membrane domains for the regulation of P. aeruginosa
infections in vivo.
5. Mycobacterium tuberculosis and other Mycobacteria
Mycobacteria belong to the most important bacteria
worldwide causing severe infections, in particular of the lung.
It is estimated that approximately 2 million humans/per year die
by M. tuberculosis infections highlighting the enormous clinical
impact of these infections.
Mycobacteria are intracellular pathogens that are internalized
by macrophages, but prevent the maturation of the mycobac-
terial phagosome and the fusion with lysosomes. Mycobacteria
are even able to replicate within phagosomes. Studies by
Gatfield and Pieters demonstrated that the integrity of rafts in
the cell membrane is required for uptake of the bacteria into
macrophages, since cholesterol-depleting reagents as methyl-β-
cyclodextrin or lovastatin prevented entry [50]. Further, cho-
lesterol accumulated at the bacterial internalization site. In
addition, intracellular survival of the bacteria requires the
recruitment of the tryptophan-aspartate containing coat protein
(TACO/Coronin 1) into the phagosomal membrane [50,72].
Depletion of cholesterol prevented the correct coating of
intracellular mycobacteria suggesting that rafts are also
involved in the phagosomal transformation after the primary
uptake of mycobacterial [50,73]. Studies by Anes et al. [74]
supported the notion that distinct membrane domains are
involved in the maturation of intracellular phagosomes. The
fusion of phagosomes with lysosomes, which results in the
formation of phagolysosomes to degrade pathogens, requires a
coordinated assembly of actin filaments on phagosomes.
Sphingolipids such as sphingosine, sphingosine-1-phosphate
and ceramide served to bind actin on phagosomes and seem to
be critical for vesicle fusion. Pathogenic mycobacteria seem toactively interfere with the formation of these sphingolipids and,
thus, are able to prevent the fusion of phagosomes with
lysosomes.
6. Prion-diseases/transmissibile spongiform
encephalopathies
Prions are a class of proteins that cause degenerative neuro-
logical disorders as Creutzfeldt–Jakob disease, BSE, Scrapie or
Kuru. Prion proteins (PrP) are a normal component of
mammalian cells, however a conformational change of the
protein into the scrapie-isofom (PrPsc) results in the disease.
The conversion of PrP seems to require intact rafts and
destruction of rafts by lowering the sphingolipid or cholesterol
concentration, respectively, in the membrane prevents the
formation of PrPsc [75–77]. However, at present it is unknown
how lipid rafts promote abnormal prion conversion.
7. HIV
HIV belongs, together with tuberculosis, to the most
important infections worldwide. No cure has been identified
so far. Therefore, a detailed understanding of the mechanisms
involved in HIV infections might open new possibilities for
treatment or even prevention of this infection.
The role of lipid rafts in HIV still requires characteriza-
tion, although many studies in the last years suggested an
important role of lipid rafts and ceramide in the infection of
human cells with HIV. The gp 120 protein of HIV initially
binds to CD4 on T-lymphocytes, which results in a con-
formational change of gp120 and a further interaction of the
virus with co-receptors, in particular CCR5 and CXCR4.
This process requires lateral diffusion and reorganization of
the human receptor molecules in the cell membrane, in
particular of CD4. Binding of gp120 to CD4, which is
constitutively present in rafts, seems to result in clustering of
rafts and CD4 [78–83]. Viral entry was very significantly
inhibited upon destruction of rafts by cholesterol-depleting
reagents, although the binding of the virus to CD4 was not
affected [80,81]. This indicates that viral entry requires rafts.
Rafts seem to contribute to two additional features of the
infectious process: First, the virus binds to glycosphingoli-
pids for instance galactosylceramides present in rafts during
the transfer of the virus through epithelial cells of the
mucosa [84]. Disruption of rafts prevents viral transcytosis.
Second, budding, i.e. the exit of HIV-particles from an
infected cell seems to occur via rafts and destruction of rafts
prevents viral budding suggesting that rafts are central for
the infection of human cells with this pathogen [80,85]. A
budding of HIV particles via rafts was recently confirmed by
a study that determined the lipid composition of the HIV
envelope [85]. This study demonstrated an enrichment of
lipids that are typically present in rafts, for instance the
sphingolipid dihydrosphingomyelin, in the HIV envelope not
only proving the budding of HIV via distinct membrane
domains, but also providing strong evidence for the exis-
tence of rafts in vivo.
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of ceramide by treatment of cells with fenretinide prevents
infection with HIV [86]. These studies indicated that the
formation of ceramide triggers the uptake of HIV into en-
docytotic vesicles and prevents HIV fusion with the cell
membrane [86]. Endocytotic internalization of the virus results
in degradation of the virus. At present, it has not been deter-
mined how ceramide prevents HIV fusion, but it is possible
that an alteration of rafts by hydrolysis of sphingomyelin and
the generation of ceramide within rafts and/or the formation of
ceramide-enriched membrane platforms prevents fusion and, at
the same time, facilitates uptake of the virus into cellular
vesicles that are capable to destroy the virus.
8. Chlamydia trachomatis
Chlamydia trachomatis and other Chlamydia species are
obligate intracellular bacteria that induce atypical pneumonia
and sexually transmitted diseases. Although not all Chlamydia
species seem to employ the same invasion pathways, the general
picture identifies rafts as central structure for the infection of
mammalian cells with Chlamydia species. In particular, the
invasion of C. trachomatis serovar D, C. pneumoniae and
C. psittaci has been shown to be inhibited by extraction
of cholesterol from lipid rafts employing methyl-β-cyclodex-
trin, nystatin or filipin, while the invasion of C. trachomatis
serovar A and C were not affected by these drugs [87,88].
Furthermore, Chlamydia species trigger the fusion of lipid
rafts to large membrane platforms [89,90] supporting the
notion of an important role of lipid rafts in the infection
process of Chlamydia species. In addition to a role of lipid
rafts in the cell membrane, it was demonstrated that
intracellular C. pneumoniae and trachomatis co-localize with
caveolin -1 and 2 [89,90], although the biological function of
this interaction is not clear yet.
9. Plasmodium falciparum
Plasmodium falciparum causes malaria, one of the most
important infectious disease worldwide besides tuberculosis
and HIV. Recent studies indicate that rafts and ceramide-
enriched membrane platforms, respectively, are not only
involved in infection of mammalian host cells with bacteria
and viruses, but also by parasites. For instance, disruption of
rafts in erythrocytes by extraction of cholesterol prevents
infection with Plasmodium falciparum [91,92]. A role of rafts
in the infection of erythrocytes by P. falciparum is also
supported by the finding that interaction of the parasites with
erythrocytes results in a dissociation of flotillins, which are
components of rafts in many cells, from detergent-resistant
membranes [92]. P. falciparum express a sphingomyelinase that
functions as a sphingomyelin/lysocholinephospholipid-phos-
pholipase C and has been shown to be required for the infection
of erythrocytes with P. falciparum [93]. Inhibition of the
enzyme prevented intra-erythrocytic proliferation [93]. This
enzyme might alter the composition of rafts to permit infection
with P. falciparum and/or trigger the formation of ceramide-enriched membrane platforms that may serve as entry sites for
the parasite.
10. Conclusion
Numerous studies in the last years demonstrated the role of
distinct membrane domains, rafts and ceramide-enriched
membrane platforms for the infection of mammalian cells by
pathogens including bacteria, viruses and parasites. Rafts and
ceramide-enriched membrane platforms, respectively, are
involved in internalization of pathogenic bacteria, viruses and
parasites, induction of apoptosis in the infected cell but also
mediation of cell proliferation, regulation of the release of
cytokines, fusion of phagosomes with lysosomes, etc. It is
surprising that rafts are involved in that many aspects of the
infection of mammalian cells with pathogens. It is therefore
very likely that rafts and ceramide-enriched membrane domains
have general functions during the infection. A primary function
of rafts and other distinct membrane domains might be the
organization of receptors and intracellular signaling proteins
that mediate the specific response to a pathogen. Further,
distinct membrane domains might mediate a re-organization of
receptors and signaling proteins upon infection, i.e. they may
serve to recruit and concentrate proteins involved in the host
response, while other proteins are excluded from the site of
infection. Thus, although distinct membrane domains and the
enzymes involved in the generation of lipid domains might
serve as novel targets for the treatment and/or prevention of
infectious diseases, the general functions of these domains
require further studies to identify specific pathways and
components suitable for treatment of specific infections.
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